This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Southwest Oncology Group Study

David E. Schuller, MD; David W. Stein, MD; Barbara Metch, MS

Arch Otolaryngol Head Neck Surg. 1989;115(7):834-836.

Abstract
• If chemotherapy is effectively controlling microscopic distant metastases, then a reduced number of patients would experience treatment failure at distant sites. This study has used a group of 175 patients on a phase 3 Southwest Oncology Group trial for resectable advanced stage disease to test this hypothesis. In the group that failed, 52% of the standard group failed at distant sites as opposed to only 30% of the experimental group. This difference approaches statistical significance. These findings suggest that chemotherapy, although demonstrating some activity against microscopic distant disease, has not substantially altered the usual patterns of treatment failure for head and neck cancer. However, the assumption that the clinical responses noted with chemotherapy are having a positive influence on the frequency of occult distant disease was supported by our results.

(Arch Otolaryngol Head Neck Surg. 1989;115:834-836)

Author Affiliations
From the Department of Otolaryngology, The Ohio State University, Columbus (Drs Schuller and Stein), and the Southwest Oncology Group, San Antonio, Tex (Ms Metch).

Footnotes
Accepted for publication January 13, 1989.

Read before the Second International Conference on Head and Neck Cancer, Boston, August 3, 1988.

Reprint requests to 456 Clinic Dr, Columbus, OH 43210 (Dr Schuller).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Polymer Delivery of Chemotherapy for Squamous Cell Carcinoma of the Head and Neck
Shikani et al.
Arch Otolaryngol Head Neck Surg 1994;120:1242-1247.
ABSTRACT  

Locoregionally Advanced Paranasal Sinus Carcinoma: Favorable Survival With Multimodality Therapy
Rosen et al.
Arch Otolaryngol Head Neck Surg 1993;119:743-746.
ABSTRACT  

Do Otolaryngologist-Head and Neck Surgeons and/or Chemotherapy Have a Role in the Treatment of Head and Neck Cancer?
Schuller
Arch Otolaryngol Head Neck Surg 1991;117:498-501.
ABSTRACT